ResearcherYokohama City UniversityActive in the last 2 years
Ryutaro Mori
Matched on ORCID iD 0000-0002-2651-4478; OpenAlex author ID A5102925348. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2014: 2 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1403 (C-FLAP study). Co-author DOI 10.1038/s41598-025-23608-5↗
- Efficacy of prolonged elemental diet therapy after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A pilot prospective randomized trial (UMIN0000… Co-author DOI 10.1016/j.clnesp.2019.07.017↗
- Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic-Can… Co-author DOI 10.1002/jcb.26224↗
- Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model r… Co-author DOI 10.1016/j.pan.2015.02.008↗
- The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. Co-author DOI 10.1371/journal.pone.0103382↗
- [A case of post-operative recurrence of pancreatic cancer in the residual pancreas treated by resection of the residual pancreas following radiological complet… Co-author PMID 25131881↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Itaru Endo · 6 shared papers, 2014–2025 · strength 0.49
- Paper Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1… DOI 10.1038/s41598-025-23608-5↗
- Paper Efficacy of prolonged elemental diet therapy after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A pilo… DOI 10.1016/j.clnesp.2019.07.017↗
- Paper Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and … DOI 10.1002/jcb.26224↗
- Yasushi Ichikawa · 5 shared papers, 2014–2025 · strength 0.40
- Paper Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1… DOI 10.1038/s41598-025-23608-5↗
- Paper Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and … DOI 10.1002/jcb.26224↗
- Paper Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient der… DOI 10.1016/j.pan.2015.02.008↗
- Kentaro Miyake · 3 shared papers, 2018–2025 · strength 0.37
- Paper Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1… DOI 10.1038/s41598-025-23608-5↗
- Paper Efficacy of prolonged elemental diet therapy after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A pilo… DOI 10.1016/j.clnesp.2019.07.017↗
- Paper Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and … DOI 10.1002/jcb.26224↗
- Noritoshi Kobayashi · 2 shared papers, 2014–2025 · strength 0.26
- Paper Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1… DOI 10.1038/s41598-025-23608-5↗
- Paper [A case of post-operative recurrence of pancreatic cancer in the residual pancreas treated by resection of the residual… PMID 25131881↗
- Eriko Katsuta · 1 shared paper, 2025 · strength 0.22
- Kensuke Kubota · 1 shared paper, 2025 · strength 0.22
- Yasuhiro Yabushita · 1 shared paper, 2025 · strength 0.22
- Yuki Homma · 2 shared papers, 2018–2019 · strength 0.16
- Paper Efficacy of prolonged elemental diet therapy after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A pilo… DOI 10.1016/j.clnesp.2019.07.017↗
- Paper Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and … DOI 10.1002/jcb.26224↗
- Michael Bouvet · 3 shared papers, 2014–2018 · strength 0.14
- Paper Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and … DOI 10.1002/jcb.26224↗
- Paper Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient der… DOI 10.1016/j.pan.2015.02.008↗
- Paper The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. DOI 10.1371/journal.pone.0103382↗
- Takashi Murakami · 3 shared papers, 2014–2018 · strength 0.14
- Paper Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and … DOI 10.1002/jcb.26224↗
- Paper Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient der… DOI 10.1016/j.pan.2015.02.008↗
- Paper The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. DOI 10.1371/journal.pone.0103382↗
- Yukihiko Hiroshima · 3 shared papers, 2014–2018 · strength 0.14
- Paper Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and … DOI 10.1002/jcb.26224↗
- Paper Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient der… DOI 10.1016/j.pan.2015.02.008↗
- Paper The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. DOI 10.1371/journal.pone.0103382↗
- Robert M. Hoffman · 3 shared papers, 2014–2018 · strength 0.14
- Paper Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and … DOI 10.1002/jcb.26224↗
- Paper Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient der… DOI 10.1016/j.pan.2015.02.008↗
- Paper The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. DOI 10.1371/journal.pone.0103382↗
- Ali A. Maawy · 2 shared papers, 2014–2015 · strength 0.08
- Paper Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient der… DOI 10.1016/j.pan.2015.02.008↗
- Paper The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. DOI 10.1371/journal.pone.0103382↗
- Ho Kyoung Hwang · 1 shared paper, 2018 · strength 0.07
- Rhiana S. Menen · 1 shared paper, 2014 · strength 0.03
- Shuya Yano · 1 shared paper, 2014 · strength 0.03
- Fuminari Uehara · 1 shared paper, 2014 · strength 0.03
- Shinji Miwa · 1 shared paper, 2014 · strength 0.03
- Mohamed K. Hassanein · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.